NOUREXAL
Live / Registered — Registered (as of 13 Feb 2024)
What this means for you
Registered since 13 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88854341
- Registration number
- 7304896
- Mark type
- Stylized text
- Filed
- 31 Mar 2020
- Published for opposition
- 19 Sept 2023
- Registered
- 13 Feb 2024
- Attorney of record
- Jessica Connarn
Goods and services
- Class 005 — Pharmaceuticals: Anti-inflammatories; Cardiovascular treatment preparations; Cardiovascular pharmaceuticals; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, injectables and pharmaceutical preparations for the treatment of cardiovascular disorders; Cardiovascular prevention preparations; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, injectables and pharmaceutical preparations for the prevention of cardiovascular disorders; Pharmaceutical preparations and substances for the treatment of aging and aging-related diseases, as well as viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, Alzheimer, gastrointestinal, hormonal, dermatological, psychiatric, mental depression and immune system related diseases and disorders; Pharmaceutical preparations and substances for the prevention of ischemia-dependent aging and aging-related diseases, including musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, Alzheimer, hormonal, dermatological, psychiatric, mental depression and immune system related diseases and disorders; Neurological Pharmaceuticals; Neurological treatment preparations; Musculoskeletal Pharmaceuticals; Vascular Pharmaceuticals; Pharmaceuticals for Prevention of Ischemic Injury; Pharmaceuticals for Prevention of Disease Progression; Cellular Energy Preservation Pharmaceuticals
Owner
- Nour Heart, Inc., Vienna, VA, US
- Nour Heart, Inc., Vienna, VA, US
- Nour Heart, Inc., Vienna, VA, US
Prosecution history
- 13 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 06 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Dec 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Dec 2023 — USE AMENDMENT FILED
- 11 Dec 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Dec 2023 — TEAS STATEMENT OF USE RECEIVED
- 29 Nov 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Nov 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Nov 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Nov 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Sept 2023 — PUBLISHED FOR OPPOSITION